-
A Quality Systems Perspective on Sensitization and Kidney Allocation System Changes Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-13 Laurel Damashek
An abstract is unavailable.
-
Acute Kidney Injury, Systemic Inflammation and Long-term Cognitive Function: ASSESS-AKI Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-10 Pavan K. Bhatraju, Leila R. Zelnick, Ian B. Stanaway, T. Alp Ikizler, Steven Menez, Vernon M. Chinchilli, Steve G. Coca, James S. Kaufman, Paul L. Kimmel, Chirag R. Parikh, Alan S. Go, Edward D. Siew, Mark M. Wurfel., Jonathan Himmelfarb
in part, by persistent systemic inflammation. Methods: ASSESS-AKI enrolled patients surviving three months after hospitalization with and without AKI matched based on demographics, comorbidities, and baseline kidney function. A subset underwent cognitive testing using the modified mini-mental status examination (3MS) at 3, 12, and 36 months. We examined the association of AKI with 3MS scores using
-
Development and external validation of a multidimensional deep learning model to dynamically predict kidney outcomes in IgA nephropathy Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-10 Tingyu Chen, Tiange Chen, Wenjie Xu, Shaoshan Liang, Feng Xu, Dandan Liang, Xiang Li, Caihong Zeng, Guotong Xie, Zhihong Liu
. This study aimed at establishing a multivariable dynamic deep learning model using comprehensive longitudinal data for the prediction of kidney outcomes in IgA nephropathy. Methods In this retrospective cohort study of 2,056 IgA nephropathy patients at 18 kidney centers, a total of 28,317 data points were collected by the sliding window method. Among them, 15,462 windows in a single center were randomly
-
A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-10 Angelina Dixon, Nisha Bansal, Susanne B. Nicholas, Anna Ostrow, Jessica Kendrick
ildcare due to nontraditional work hours with extended or unpredictable shifts. Here, we examine awareness of current policies in United States (US) nephrology fellowship programs regarding parental leave, pregnancy/breastfeeding accommodations, and fellows’ perspectives on family planning. Methods: An anonymous, on-line survey of US nephrology fellows was undertaken from June 9 to August, 24, 2023
-
Unexplained Metabolic Alkalosis in an Athlete: Don’t Sweat It Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-10 Roger Rodby, William Whittier
An abstract is unavailable. This article is available as a PDF only.
-
Association of Preterm Birth with Adverse Glomerular Disease Outcomes in Children and Adults Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-10 Jaya Isaac, Jonathan Troost, Yujie Wang, Kelly Garrity, Frederick Kaskel, Rasheed Gbadegesin, Kimberly Reidy
glomerular disease are unknown. Methods: We performed a cross-sectional and longitudinal analysis of participants in the Cure Glomerulonephropathy (CureGN) cohort. Preterm (<37 weeks’ gestation) was compared to term (≥37 weeks’ gestation). A survival analysis and adjusted Cox proportional hazards model were used to examine a composite outcome of 40% decline in estimated glomerular filtration rate (eGFR)
-
Kidney Transplant of the Undocumented Immigrant: A Proposal Whose Benefits Outweigh the Status Quo Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-06 George N. Coritsidis, Adam Block, Isaac Pak, Rajkumar S. Pammal
An abstract is unavailable. This article is available as a PDF only.
-
Rates of Heart Failure with Preserved Ejection Fraction in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-06 Khalid Namoos, Cheng-Wei Huang, In-Lu Amy Liu, Janet S. Lee, David K. Yi, John J. Sim
An abstract is unavailable. This article is available as a PDF only.
-
Longitudinal plasma metabolome patterns and relation to kidney function and proteinuria in pediatric chronic kidney disease Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-06 Arthur M. Lee, Yunwen Xu, Jian Hu, Rui Xiao, Stephen R. Hooper, Erum A. Hartung, Josef Coresh, Eugene P. Rhee, Ramachandran S. Vasan, Paul L. Kimmel, Bradley A. Warady, Susan L. Furth, Michelle R. Denburg, on behalf of the CKD Biomarkers Consortium*
is a limited number of studies of longitudinal metabolomics, and virtually none in pediatric CKD. Methods The Chronic Kidney Disease in Children (CKiD) study is a multi-institutional, prospective cohort that enrolled children aged six-months to 16-years with estimated glomerular filtration rate (eGFR) 30-90ml/min/1.73m2. Untargeted metabolomics profiling was performed on plasma samples from the baseline
-
Podocyte-targeted therapies — progress and future directions Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-05-09 Kristin Meliambro, John C. He, Kirk N. Campbell
-
Spatial transcriptomics in health and disease Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-05-08 Sanjay Jain, Michael T. Eadon
-
A patient perspective on kidney disease in the public health agenda Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-05-07 Daniel Gallego
Chronic kidney disease is a life-changing diagnosis for millions of people worldwide, as the risk of disease progression and kidney failure creates unbearable uncertainty and limits lifestyle. The devastating impact of advanced kidney disease must be acknowledged in the public health agenda to pave way for improved outcomes for patients at all stages of disease.
-
Genomic Testing in Patients with Kidney Failure of an Unknown Cause: a National Australian Study Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-05-03 Amali C. Mallawaarachchi, Lindsay Fowles, Louise Wardrop, Alasdair Wood, Rosie O’Shea, Erik Biros, Trudie Harris, Stephen I Alexander, Simon Bodek, Neil Boudville, Jo Burke, Leslie Burnett, Sarah Casauria, Steve Chadban, Aron Chakera, Sam Crafter, Pei Dai, Paul De Fazio, Randall Faull, Andrew Honda, Vanessa Huntley, Sadia Jahan, Kushani Jayasinghe, Matthew Jose, Anna Leaver, Mandi MacShane, Evanthia
rs of etiology. We aimed to determine the diagnostic utility of whole-genome sequencing (WGS) with analysis of a broad kidney gene panel in patients with kidney failure of unknown cause. Methods We prospectively recruited 100 participants who reached CKD stage 5 at 50 years of age and had an unknown cause of kidney failure after standard investigation. Clinically-accredited WGS was performed in this
-
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV Kidney Int. (IF 19.6) Pub Date : 2024-05-01 Annegret Pelchen-Matthews, Amanda Mocroft, Lene Ryom, Michael J. Ross, Shweta Sharma, Steven Coca, Amit Achhra, Elaine Cornell, Russell Tracy, Andrew Phillips, Marta Montero Alonso, Giota Toulomi, Brian K. Agan, Nicholas Medland, Christina M. Wyatt, INSIGHT START Study Group
-
Outpatient Nephrology Follow-Up after Community-Acquired Acute Kidney Injury among United States Veterans Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-26 Clarissa J. Diamantidis, Lindsay Zepel, Matthew L. Maciejewski, M. Alan Brookhart, C. Barrett Bowling, Virginia Wang
An abstract is unavailable. This article is available as a PDF only.
-
Role of the gut microbiota in the pathogenesis of IgA nephropathy Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-29 Ellen F. Carney
The microbiome can modulate immune responses and has an important effect on human health, but its potential causal role in acquired autoimmune diseases remains to be determined. Now, James Gleeson, Renato Monteiro and colleagues report a mechanism by which gut microbial dysbiosis could contribute to the pathogenesis of IgA nephropathy (IgAN). As the mucin layer on the luminal side of the gut wall contains
-
Podocyte-derived soluble RARRES1 drives kidney disease progression through direct podocyte and proximal tubular injury Kidney Int. (IF 19.6) Pub Date : 2024-04-30 Ye Feng, Zeguo Sun, Jia Fu, Fang Zhong, Weijia Zhang, Chengguo Wei, Anqun Chen, Bi-Cheng Liu, John C. He, Kyung Lee
-
Utility of Blood Biomarkers to Predict Marrow Iron Stores in Children Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-30 Shilpa Sharma, Renata C. Pereira, Elizabeta Nemeth, Mark R. Hanudel, Joachim H. Ix, Isidro B. Salusky, Tomas Ganz
d standard) in this population with kidney failure who underwent bone biopsies. Methods: This cross-sectional study enrolled 71 clinically stable children and young adults receiving dialysis who underwent bone biopsy for chronic kidney disease-mineral bone disorder between 2007 through 2011. Bone biopsies were stained with Perls’ Prussian blue and independently interpreted by a pathologist blinded
-
Assessment of biological organ age using molecular pathology in pre-transplant kidney biopsies Kidney Int. (IF 19.6) Pub Date : 2024-04-29 Roy Zhang, Patrick B. Trotter, James McCaffrey, Rory Fitzroy, Giorgio Trivioli, Benjamin J. Stewart, John R. Ferdinand, Kevin W. Loudon, Alexandra Riding, Jonathan West, Ashley Ferro, Menna R. Clatworthy
-
High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients Kidney Int. (IF 19.6) Pub Date : 2024-04-27 Laura Donadeu, Thomas Jouve, Sofia Bin, Susan Hartzell, Elena Crespo, Alba Torija, Marta Jarque, Delphine Kevella, José Zúñiga, Weijia Zhang, Zeguo Sun, Alberto Verlato, Mónica Martínez-Gallo, Cristina Font-Miñarro, Maria Meneghini, Nestor Toapanta, Irina B. Torres, Joana Sellarés, Manel Perelló, Hannah Kaminski, Lionel Couzi, Alexandre Loupy, Gaetano La Manna, Francesc Moreso, Paolo Cravedi, Oriol
-
A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease Kidney Int. (IF 19.6) Pub Date : 2024-04-27 Daniel P. Murphy, Julian Wolfson, Scott Reule, Kirsten L. Johansen, Areef Ishani, Paul E. Drawz
-
Progression and outcomes of rare kidney diseases Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-26 Susan J. Allison
To describe kidney and patient outcomes for individuals with rare diseases in the UK, Gale and colleagues analysed data from 27,285 patients with 28 different types of rare kidney disease in RaDaR. Over a median follow-up of 9.6 years, RaDaR participants had a significantly higher 5-year cumulative incidence of kidney failure than that of 2.81 million patients with all-cause CKD (28% versus 1%; P < 0
-
Applications of SGLT2 inhibitors beyond glycaemic control Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-26 Daniel V. O’Hara, Carolyn S. P. Lam, John J. V. McMurray, Tae Won Yi, Samantha Hocking, Jessica Dawson, Smriti Raichand, Andrzej S. Januszewski, Meg J. Jardine
-
Post-translational modifications in kidney diseases and associated cardiovascular risk Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-25 Heidi Noels, Vera Jankowski, Stefan J. Schunk, Raymond Vanholder, Sahir Kalim, Joachim Jankowski
-
Not every organ ticks the same Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-24 Khaoula Talbi, Anette Melk
-
Immune mechanisms in the pathophysiology of hypertension Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-24 Bianca A. Nguyen, Matthew R. Alexander, David G. Harrison
-
Considerations of sex as a binary variable in clinical algorithms Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-23 Dinushika Mohottige, Samira Farouk, Tonia Poteat, Asa Radix, Selma Feldman Witchel
Clinical algorithms that are used to guide medical decision-making often include sex as a variable. However, binary considerations of sex and/or gender might introduce bias due to potentially inaccurate assumptions about sex and gender-specific physiology, hormones and exposures. An equity-focused approach to sex and gender is essential when using clinical algorithms to ensure health equity across
-
Kinetics of Beta2-Microglobulin with Hemodiafiltration and High-Flux Hemodialysis Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-23 Richard A. Ward, John T. Daugirdas
emodialysis. The impact of hemodiafiltration on beta-2-microglobulin levels was evaluated by modeling four randomized studies of hemodiafiltration vs. hemodialysis. The impact of residual kidney function on beta-2-microglobulin was tested by comparing results of previously reported measured data with model predictions. Results: In the low-flux and high-flux arms of the HEMO study, measured median
-
Calcium signalling and transport in the kidney Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-19 Alexander Staruschenko, R. Todd Alexander, Michael J. Caplan, Daria V. Ilatovskaya
-
Hypertension and Proteinuria in a Pregnancy: A Quiz Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-04-19 Massimo Torreggiani, Maria Rita Stancanelli, Linda Njandjo, Antioco Fois, Giorgina Barbara Piccoli
-
Thiazides in kidney transplant recipients: skin in the game Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-17 Steven Van Laecke
-
Epithelial cell states associated with kidney and allograft injury Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-17 Christian Hinze, Svjetlana Lovric, Philip F. Halloran, Jonathan Barasch, Kai M. Schmidt-Ott
-
Time is Money: Protected Time for Fellow Education Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-17 Alice M. Sheridan
An abstract is unavailable.
-
The Clinical Study of Kidney Stone Disease and the Value of Specificity Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-17 Alan C. Pao, Calyani Ganesan
An abstract is unavailable.
-
Did the SCORED Trial Get Extra Points for Kidney Outcomes? If So, It Is Not Obvious Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-17 Nupur Mistry, George L. Bakris
An abstract is unavailable.
-
The key role of altered tubule cell lipid metabolism in kidney disease development Kidney Int. (IF 19.6) Pub Date : 2024-04-16 Lauren E. Lee, Tomohito Doke, Dhanunjay Mukhi, Katalin Susztak
Kidney epithelial cells have very high energy requirements, which are largely met by fatty acid oxidation. Complex changes in lipid metabolism are observed in patients with kidney disease. Defects in fatty acid oxidation and increased lipid uptake, especially in the context of hyperlipidemia and proteinuria, contribute to this excess lipid build-up and exacerbate kidney disease development. Recent
-
Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-16 Robert A. Fletcher, William G. Herrington, Rajiv Agarwal, Kaitlin J. Mayne, Clare Arnott, Meg J. Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Natalie Staplin, David C. Wheeler, Glenn M. Chertow, Hiddo J. L. Heerspink, Brendon L. Neuen
An abstract is unavailable. This article is available as a PDF only.
-
NELL-1–associated membranous nephropathy linked to skin fairness cream use: insights from an Indian case series Kidney Int. (IF 19.6) Pub Date : 2024-04-12 Ranjit Narayanan, Sajeesh Sivadas, Anila Abraham Kurien
-
Association of Inflammatory Bowel Disease with Incident Immunoglobulin A Nephropathy Clin. J. Am. Soc. Nephrol. (IF 9.8) Pub Date : 2024-04-11 Takashin Nakayama, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Katsuhito Fujiu, Norifumi Takeda, Hiroyuki Morita, Norihiko Takeda, Akira Fukui, Takashi Yokoo, Hideo Yasunaga, Masaomi Nangaku, Kaori Hayashi
sing a large-scale epidemiological cohort. Methods We retrospectively analyzed 4,311,393 adults enrolled in the JMDC Claims Database (previously known as the Japan Medical Data Center database), a nationwide epidemiological database in Japan. The definitions of IgA nephropathy and inflammatory bowel disease (ulcerative colitis or Crohn’s disease) were based on International Classification of Diseases-10th
-
Deciphering missense coding variants with AlphaMissense Kidney Int. (IF 19.6) Pub Date : 2024-04-10 Zhicheng Pan, Chandra L. Theesfeld
-
Requiem for Urate Lowering in CKD? J. Am. Soc. Nephrol. (IF 13.6) Pub Date : 2024-04-10 David B. Mount
An abstract is unavailable.
-
“Atypical” Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All? Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-04-09 Vanja Ivković MD PhD, Andreas Kronbichler MD PhD, Tiffany N. Caza MD PhD
-
In Reply to “‘Atypical’ Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?” Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-04-09 Bertrand Chauveau MD, Jean-Baptiste Gibier MD PhD, Marion Rabant MD PhD
-
Equity in Preemptive Kidney Transplantation: The Case for Caution J. Am. Soc. Nephrol. (IF 13.6) Pub Date : 2024-04-08 Robert W. Steiner
An abstract is unavailable.
-
Consent for High–Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right J. Am. Soc. Nephrol. (IF 13.6) Pub Date : 2024-04-08 Peter Stock, Charles Gerard Rickert
An abstract is unavailable.
-
Kidney Endothelial Cell Biology in Health and Disease J. Am. Soc. Nephrol. (IF 13.6) Pub Date : 2024-04-08 Sargis Sedrakyan
An abstract is unavailable.
-
Renal Intercalated Cell Differentiation and Acid–Base Regulation J. Am. Soc. Nephrol. (IF 13.6) Pub Date : 2024-04-08 Carsten A. Wagner
An abstract is unavailable.
-
It Is Time to Replace the Term “Patient Care Technician” in Dialysis Am. J. Kidney Dis. (IF 13.2) Pub Date : 2024-04-07 Laura C. Plantinga, Danilo B. Concepcion, Susan A. Chapman, Jennifer Craft Morgan, Fran Rickenbach, Clarica Douglas-Ajayi, Delphine S. Tuot, Bernard G. Jaar, Megan Urbanski
-
Implementation science: a tool to narrow know-do gap and widen equity in kidney diseases and transplantation Kidney Int. (IF 19.6) Pub Date : 2024-04-06 Ekamol Tantisattamo
-
The authors reply Kidney Int. (IF 19.6) Pub Date : 2024-04-06 Winston W.S. Fung, Valerie A. Luyckx, Katherine R. Tuttle, writing team and the World Kidney Day Joint Steering Committee
-
Bridging the knowledge–practice gap in kidney care: insights from a medical student in Thailand Kidney Int. (IF 19.6) Pub Date : 2024-04-06 Abhishet Varama
-
The authors reply Kidney Int. (IF 19.6) Pub Date : 2024-04-06 Winston W.S. Fung, Valerie A. Luyckx, Katherine R. Tuttle, World Kidney Day Joint Steering Committee, Alessandro Balducci, Vassilios Liakopoulos, Li-Li Hsiao, Ricardo Correa-Rotter, Ifeoma Ulasi, Latha Kumaraswami, Siu Fai Lui, Dina Abdellatif, Ágnes Haris
-
Kidney disease: a global health priority Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-03
The prevalence of kidney disease and its associated morbidity and mortality continue to rise. This crisis cannot be tackled unless kidney disease is made a global public health priority.
-
A new era in the science and care of kidney diseases Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-04 Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivek Jha, Carol Pollock, Katherine Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Giuseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, Raymond Vanholder
Notable progress in basic, translational and clinical nephrology research has been made over the past five decades. Nonetheless, many challenges remain, including obstacles to the early detection of kidney disease, disparities in access to care and variability in responses to existing and emerging therapies. Innovations in drug development, research technologies, tissue engineering and regenerative
-
-
Time for action: recognizing chronic kidney disease as a major noncommunicable disease driver of premature mortality Kidney Int. (IF 19.6) Pub Date : 2024-04-04 Germaine Wong, Amélie Bernier-Jean, Brad Rovin, Pierre Ronco, Editors of Kidney International
-
Combination therapy for kidney disease in people with diabetes mellitus Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-03 Daniël H. van Raalte, Petter Bjornstad, David Z. I. Cherney, Ian H. de Boer, Paola Fioretto, Daniel Gordin, Frederik Persson, Sylvia E. Rosas, Peter Rossing, Jennifer A. Schaub, Katherine Tuttle, Sushrut S. Waikar, Hiddo J. L. Heerspink
Diabetic kidney disease (DKD), defined as co-existing diabetes and chronic kidney disease in the absence of other clear causes of kidney injury, occurs in approximately 20–40% of patients with diabetes mellitus. As the global prevalence of diabetes has increased, DKD has become highly prevalent and a leading cause of kidney failure, accelerated cardiovascular disease, premature mortality and global
-
Chronic kidney disease and the global public health agenda: an international consensus Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-03 Anna Francis, Meera N. Harhay, Albert C. M. Ong, Sri Lekha Tummalapalli, Alberto Ortiz, Agnes B. Fogo, Danilo Fliser, Prabir Roy-Chaudhury, Monica Fontana, Masaomi Nangaku, Christoph Wanner, Charu Malik, Anne Hradsky, Dwomoa Adu, Sunita Bavanandan, Ana Cusumano, Laura Sola, Ifeoma Ulasi, Vivekanand Jha
Early detection is a key strategy to prevent kidney disease, its progression and related complications, but numerous studies show that awareness of kidney disease at the population level is low. Therefore, increasing knowledge and implementing sustainable solutions for early detection of kidney disease are public health priorities. Economic and epidemiological data underscore why kidney disease should
-
The global landscape of kidney registries: immense challenges and unique opportunities Nat. Rev. Nephrol. (IF 41.5) Pub Date : 2024-04-02 Christopher H. Grant, Fergus J. Caskey, M. Razeen Davids, Manisha Sahay, Aminu K. Bello, Dorothea Nitsch, Samira Bell
Kidney registries are essential to understanding the burden of kidney disease and facilitating the development of sustainable and effective programs for kidney disease prevention and care. Key barriers to implementation of registries at a global scale include funding and data quality. These issues warrant the attention of the global nephrology community.
-
CAR T-cell therapy—paving the way for sensitized kidney transplant patients Kidney Int. (IF 19.6) Pub Date : 2024-04-02 Tambi Jarmi, Yan Luo, Rose Mary Attieh, Yaqing Qie, Martha E. Gadd, Tanya Hundal, Shennen Mao, Hemant S. Murthy, Burcin C. Taner, Mohamed A. Kharfan-Dabaja, Hong Qin